Jiangxi Fushine Pharmaceutical Co Ltd (300497) — Cash Flow Quality Index
Jiangxi Fushine Pharmaceutical Co Ltd (300497) has a Cash Flow Quality Index of 16.37x as of March 2025. Operating cash flow of CN¥36.65 Million exceeds net income of CN¥2.24 Million, indicating high earnings quality where cash backs reported profits. Explore 300497 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangxi Fushine Pharmaceutical Co Ltd Cash Flow Quality Index (2012–2021)
Historical Cash Flow Quality Index for Jiangxi Fushine Pharmaceutical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300497 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jiangxi Fushine Pharmaceutical Co Ltd (2012–2021)
Year-by-year earnings quality comparison for Jiangxi Fushine Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Jiangxi Fushine Pharmaceutical Co Ltd stock valuation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2021 | 1.83x | CN¥72.32 Million | CN¥39.54 Million | ▲ +54.1% |
| 2020 | 1.19x | CN¥382.35 Million | CN¥322.18 Million | ▲ +7.8% |
| 2019 | 1.10x | CN¥337.91 Million | CN¥306.88 Million | ▲ +20.4% |
| 2018 | 0.91x | CN¥175.91 Million | CN¥192.36 Million | ▼ -24.3% |
| 2017 | 1.21x | CN¥210.72 Million | CN¥174.48 Million | ▲ +10.5% |
| 2016 | 1.09x | CN¥188.53 Million | CN¥172.52 Million | ▲ +38.2% |
| 2015 | 0.79x | CN¥74.01 Million | CN¥93.60 Million | ▲ +34.6% |
| 2014 | 0.59x | CN¥31.39 Million | CN¥53.44 Million | ▼ -53.7% |
| 2013 | 1.27x | CN¥57.22 Million | CN¥45.07 Million | ▼ -19.5% |
| 2012 | 1.58x | CN¥63.20 Million | CN¥40.08 Million | — |